Innova Captab Limited's (NSE:INNOVACAP) 25% Share Price Plunge Could Signal Some Risk
Feb 19
Have your own idea? Try our Stock Screener
Indian (NIFTY) Life Sciences Industry Analysis
UpdatedFeb 21, 2025
DataAggregated Company Financials
Companies19
- 7D-1.2%
- 3M-5.3%
- 1Y44.3%
- YTD-7.7%
Over the last 7 days, the Life Sciences industry has dropped 3.4%, driven by OneSource Specialty Pharma declining 8.8%. In contrast, Jeevan Scientific Technology has gained 15%. This takes the industry's 12 month performance to a gain of 39%. Earnings are forecast to grow by 23% annually.
Industry Valuation and Performance
Has the Indian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 21 Feb 2025 | ₹2.6t | ₹287.4b | ₹30.8b | 50.2x | 83.7x | 9x |
| Sun, 19 Jan 2025 | ₹2.5t | ₹269.1b | ₹30.1b | 50.9x | 83.6x | 9.3x |
| Tue, 17 Dec 2024 | ₹2.4t | ₹254.2b | ₹28.8b | 49.2x | 81.6x | 9.3x |
| Thu, 14 Nov 2024 | ₹2.3t | ₹252.1b | ₹28.2b | 46.5x | 82.4x | 9.2x |
| Sat, 12 Oct 2024 | ₹2.5t | ₹247.6b | ₹26.3b | 50.7x | 93.7x | 9.9x |
| Mon, 09 Sep 2024 | ₹2.2t | ₹247.6b | ₹26.3b | 50.2x | 84x | 8.9x |
| Wed, 07 Aug 2024 | ₹1.9t | ₹205.8b | ₹24.7b | 37x | 77.3x | 9.3x |
| Fri, 05 Jul 2024 | ₹1.8t | ₹202.0b | ₹23.9b | 35.7x | 74.2x | 8.8x |
| Sun, 02 Jun 2024 | ₹1.7t | ₹195.1b | ₹21.6b | 31.8x | 76.4x | 8.5x |
| Tue, 30 Apr 2024 | ₹1.5t | ₹167.8b | ₹18.7b | 30.9x | 79.1x | 8.8x |
| Thu, 28 Mar 2024 | ₹1.3t | ₹168.5b | ₹18.6b | 27.9x | 70.4x | 7.8x |
| Sat, 24 Feb 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 31.5x | 75.9x | 8.4x |
| Mon, 22 Jan 2024 | ₹1.4t | ₹165.9b | ₹18.9b | 31.5x | 73.3x | 8.3x |
| Wed, 20 Dec 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 21.5x | 75.4x | 8.7x |
| Fri, 17 Nov 2023 | ₹1.3t | ₹156.5b | ₹18.1b | 21.5x | 73x | 8.4x |
| Sun, 15 Oct 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 25.7x | 70.9x | 9x |
| Tue, 12 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 25.9x | 72.1x | 9.2x |
| Thu, 10 Aug 2023 | ₹1.4t | ₹158.4b | ₹23.2b | 30.5x | 60.7x | 8.9x |
| Sat, 08 Jul 2023 | ₹1.4t | ₹157.2b | ₹23.0b | 28.7x | 59.2x | 8.7x |
| Mon, 05 Jun 2023 | ₹1.3t | ₹157.4b | ₹23.1b | 28.4x | 56.4x | 8.3x |
| Wed, 03 May 2023 | ₹1.2t | ₹162.6b | ₹28.7b | 33.9x | 42.5x | 7.5x |
| Fri, 31 Mar 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 31.1x | 37x | 6.6x |
| Sun, 26 Feb 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 32.3x | 38x | 6.8x |
| Tue, 24 Jan 2023 | ₹1.2t | ₹164.9b | ₹34.5b | 30x | 35.5x | 7.4x |
| Thu, 22 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 31.2x | 36.2x | 7.6x |
| Sat, 19 Nov 2022 | ₹1.2t | ₹164.4b | ₹34.8b | 29.2x | 34.5x | 7.3x |
| Mon, 17 Oct 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 36.3x | 35.1x | 7.7x |
| Wed, 14 Sep 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 38.3x | 36.3x | 8x |
| Fri, 12 Aug 2022 | ₹1.4t | ₹159.7b | ₹34.3b | 35.4x | 39.8x | 8.6x |
| Sun, 10 Jul 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 32.9x | 37.9x | 8.2x |
| Tue, 07 Jun 2022 | ₹1.2t | ₹158.3b | ₹34.2b | 31.4x | 35.8x | 7.7x |
| Thu, 05 May 2022 | ₹1.5t | ₹149.3b | ₹29.2b | 35.5x | 50.9x | 10x |
| Sat, 02 Apr 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 35.1x | 51.5x | 10.2x |
| Mon, 28 Feb 2022 | ₹1.4t | ₹148.3b | ₹29.4b | 31.7x | 48.1x | 9.5x |
Price to Earnings Ratio
48.1x
Current Industry PE
- Investors are optimistic on the Indian Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 81.7x which is higher than its 3-year average PE of 60.6x.
- The industry is trading close to its 3-year average PS ratio of 8.5x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 25% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | -0.74% | |
| Healthcare | -1.69% | |
| Life Sciences | -1.19% | |
| Clinical Research and Equipment | -1.19% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SAILIFE Sai Life Sciences | ₹734.30 | 8.0% +₹11.3b | n/a | PE110.7x | |
| SYNGENE Syngene International | ₹714.60 | 1.8% +₹4.9b | -4.5% | PE57.2x | |
| 544184 Borosil Scientific | ₹143.40 | 0.7% +₹88.9m | n/a | PE46.5x | |
| 538837 Jeevan Scientific Technology | ₹47.43 | 7.8% +₹54.5m | -15.2% | PE107.2x | |
| 511509 Vivo Bio Tech | ₹40.91 | 6.2% +₹38.7m | -8.3% | PE9.5x |
